Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 973 of 5804
-
Placental patch could help shoulder tears heal better
Disease control Recruiting nowThe rotator cuff is a set of muscles and tendons that help move the shoulder. Tears in the rotator cuff are common, particularly as people age. Consequently, rotator cuff repair surgeries are common, as well. Despite the frequency with which rotator cuff repairs are performed, th…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Sound and light training may bring back sight after stroke
Symptom relief Not yet recruitingThis study seeks to determine the extent of the visual capabilities that can be restored in hemianopic stroke patients by a multisensory training technique and evaluate changes in the brain that the training induces. The effectiveness of the technique will be evaluated in two int…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New gel could fight fungal eye infections
Disease control Not yet recruitingA Phase II, Multi-center, Randomized, Masked, Parallel-Control Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% PVP-Iodine) Gel Forming Ophthalmic Solution in the Treatment of Fungal Keratitis.
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Oxygen chamber therapy put to the test for dozens of diseases
Disease control Not yet recruitingThis study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoi…
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Gene test picks patients for targeted immunotherapy trial
Disease control Not yet recruitingThis is a Phase 2, single-arm, multicenter study, evaluating the anti-tumor efficacy of tumor-infiltrating lymphocyte (TIL) directed tislelizumab monotherapy (also known as BGB-A317) for refractory solid tumors in approximately 72 patients with centrally confirmed T cell inflamed…
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New Gel-Like wrap could stop chronic pain after cancer reconstruction
Prevention Not yet recruitingRadial forearm free flap (RFFF) reconstruction is commonly used for head and neck defects but is associated with donor-site morbidity, including neuropathic pain and sensory disturbance. This randomized controlled pilot study evaluates whether placement of a soft tissue matrix ov…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jul 11, 2026 00:00 UTC
-
Neck injection aims to fix PTSD sleep problems
Symptom relief Not yet recruitingPost-traumatic stress disorder (PTSD) is a chronic disorder that develops following exposure to trauma, and is characterized by intrusive experiences, avoidance, cognitive-emotional changes, and hyperarousal. It is based on a complex noradrenergic dysregulation. The amygdala acti…
Phase: NA • Sponsor: sara dichtwald • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Radioactive drug targets hard-to-treat neuroendocrine tumors in early trial
Disease control Not yet recruitingPhase I dose escalation study of 211At-MABG in adults with advanced pheochromocytoma / paraganglioma (PPGL) or other NET-overexpressing cancers (as evidenced by positive MIBG imaging) who are refractory to, lacking, or ineligible for approved treatments. Phase 1 dose-escalation w…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug XTX501 takes aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis is a first-in-human, multicenter, Phase 1/2, open-label study designed to evaluate the safety and tolerability of XTX501 as monotherapy in participants with metastatic non-small cell lung cancer (NSCLC) and select advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Tailored sound waves may sharpen the mind
Symptom relief Not yet recruitingThis study aims to evaluate whether personalized gamma-frequency auditory stimulation enhances cognitive function and brain synchronization. While 40 Hz auditory stimulation has been widely studied, recent evidence suggests optimal frequencies vary by individual. Using a cross-ov…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Tiny incision, big relief: new device could transform carpal tunnel surgery
Symptom relief Not yet recruitingCarpal tunnel syndrome surgery is one of the most common procedures in orthopedic and trauma surgery. Traditionally performed via an open incision or endoscopically, this procedure aims to decompress the median nerve by cutting the transverse carpal ligament. However, these techn…
Phase: NA • Sponsor: Clinique Saint François, Nice, France • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Pineapple enzyme gel could revolutionize wound care for leg ulcers
Disease control Not yet recruitingThis is a pharmacokinetics (PK) study - the main objective of this study is to assess the PK, safety and clinical performance of 5% EscharEx (EX-03 formulation) in debridement of Venous Leg Ulcers
Phase: PHASE2 • Sponsor: MediWound Ltd • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Dissolving screws could spare ankle fracture patients a second surgery
Disease control Not yet recruitingAnkle fractures are among the most common injuries that need surgery. When the broken bones make the ankle unstable, surgeons usually fix them with metal screws and plates. Metal hardware holds the bones in place well, but it can cause irritation, can loosen or break, and often h…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Chemotherapy drug temozolomide under review for tough pituitary tumors
Disease control Not yet recruitingTemozolomide is the main chemotherapy drug used for aggressive pituitary tumors and pituitary carcinomas that do not respond to standard treatments like surgery or radiation. Most of what is known about how well this treatment works comes from small studies in Europe and the Unit…
Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can a laser beam speed recovery from heart bypass surgery?
Disease control Not yet recruitingThis randomized, double-blind clinical trial aims to evaluate the impact of photobiomodulation therapy on postoperative outcomes in patients undergoing coronary artery bypass grafting (CABG). The study will compare two techniques for saphenous vein graft harvesting: the conventio…
Phase: NA • Sponsor: Federal University of São Paulo • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could Urine-Derived exosomes or ozone therapy restore erections after prostate cancer surgery?
Disease control Not yet recruitingThis prospective, randomized, controlled trial aims to evaluate and compare the therapeutic efficacy of intracavernosal urine-derived exosomes and systemic rectal ozone therapy in patients experiencing erectile dysfunction (ED) post-robotic-assisted radical prostatectomy (RARP). …
Phase: NA • Sponsor: Medipol University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Robotic glove and virtual reality team up to rehabilitate Stroke-Affected hands
Disease control Not yet recruitingThis pilot study will test whether the GRIP program-a soft robotic glove with virtual-reality training-can improve hand and arm function in adults undergoing inpatient rehabilitation after a recent stroke. About 20 participants will be randomly assigned to either the GRIP program…
Phase: NA • Sponsor: Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Smartwatches track hidden heart risk in blood cancer patients
Knowledge-focused Not yet recruitingThis study looks at how often atrial fibrillation (AF), an irregular heart rhythm, occurs in people with certain blood cancers who are starting a type of cancer medicine called a Bruton's tyrosine kinase inhibitor (BTKI). Researchers will follow 400 people starting BTKI therapy a…
Sponsor: Tina Baykaner • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Smartphone program aims to boost hope and recovery in oral cancer survivors
Symptom relief Not yet recruitingThe goal of this study (exploratory sequential design; mixed-methods study) is to evaluate whether a PERMA-H model mobile-based rehabilitation support program delivered to post-tracheostomy oral cancer patients can improve psychological and rehabilitation outcomes, compared with …
Phase: NA • Sponsor: Hainan Medical College • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Which diuretic protects a new kidney best? a Head-to-Head trial puts furosemide and mannitol to the test
Disease control Not yet recruitingDelayed graft function, defined as the need for dialysis within seven days of kidney transplantation, is a common complication affecting deceased-donor kidney transplant recipients. It is associated with prolonged hospitalization, increased healthcare costs, higher rates of acute…
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC